Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Q3 2024 Earnings Call Transcript
Operator: Good morning. My name is Alan, and I will be your conference operator today.
No. | Hedge Fund | Shares | Value | Activity | % Port |
---|---|---|---|---|---|
1. | Perceptive Advisors Joseph Edelman | 2,125,649 | $6,887,103 | 0.14% | |
2. | Alyeska Investment Group Anand Parekh | 2,023,420 | $6,555,881 | +11% | 0.03% |
3. | 683 Capital Partners Ari Zweiman | 2,000,000 | $6,480,000 | +34% | 0.49% |
4. | Almitas Capital Ron Mass | 1,988,563 | $6,442,944 | +5% | 2.27% |
5. | Citadel Investment Group Ken Griffin | 1,899,560 | $6,154,574 | +42% | 0% |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$2.53 | 40,000 | 233,464 | 2024-09-12 | Filing | ||
$2.13 | 50,000 | 55,000 | 2024-09-05 | Filing | ||
$2.20 | 100,000 | 858,571 | 2024-09-03 | Filing | ||
$1.89 | 2,250 | 5,000 | 2024-05-15 | Filing | ||
$1.89 | 2,750 | 2,750 | 2024-05-14 | Filing |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$3.20 | 18,589 | 3,120,569 | 2024-09-30 | Filing | ||
$3.20 | 18,589 | 3,220,569 | 2024-09-30 | Filing | ||
$3.20 | 11,442 | 143,801 | 2024-09-30 | Filing | ||
$3.20 | 8,709 | 142,768 | 2024-09-30 | Filing | ||
$1.88 | 10,455 | 151,477 | 2024-05-15 | Filing |
No. | Name | Shares | Value | % Port |
---|---|---|---|---|
1. | 5,275,566 | $77,656,332 | 0% | |
2. | 4,002,334 | $58,914,357 | 0% | |
3. | 2,830,243 | $41,661,177 | 0% | |
4. | 1,441,402 | $21,217,437 | 0% | |
5. | 1,436,151 | $21,140,143 | 0% |